Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ra Capital Management, Llc

Affiliations

  • Large Shareholder, Director at Satsuma Pharmaceuticals Inc. (STSA), 2019-09-17
  • Large Shareholder, Director at Ra Pharmaceuticals Inc. (RARX), 2019-06-13
  • Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2019-04-15
  • Large Shareholder, Director at Wave Life Sciences Ltd. (WVE), 2019-01-28
  • Large Shareholder at Synthorx Inc. (THOR), 2018-12-13
  • Large Shareholder at Eiger Biopharmaceuticals Inc. (EIGR), 2018-10-25
  • Large Shareholder, Director at Kala Pharmaceuticals Inc. (KALA), 2018-10-05
  • Other at Arvinas Inc. (ARVN), 2018-10-03
  • Director at Eidos Therapeutics Inc. (EIDX), 2018-06-22
  • Large Shareholder at Dicerna Pharmaceuticals Inc (DRNA), 2017-12-21
  • Large Shareholder, Director at Kalvista Pharmaceuticals Inc. (KALV), 2017-10-16
  • Other at G1 Therapeutics Inc. (GTHX), 2017-05-24
  • Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2016-09-19
  • Other at Sangamo Biosciences Inc (SGMO), 2015-02-19
  • Other at Achillion Pharmaceuticals Inc (ACHN), 2015-01-20
  • Other at Derma Sciences Inc. (DSCI), 2014-01-13
  • Large Shareholder at Biospecifics Technologies Corp (BSTC), 2010-02-26
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
STSA $15.00 1,333,333 Large Shareholder, Director 4,681,858 2019-09-17 Filing
SCPH $2.70 389,862 Large Shareholder 3,247,005 2019-04-11 Filing
WVE $38.00 263,158 Large Shareholder, Director 7,775,207 2019-01-24 Filing
RARX $15.50 1,006,452 Large Shareholder, Director 4,858,260 2018-12-12 Filing
THOR $11.00 4,545,455 Large Shareholder 9,724,598 2018-12-11 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACRS $24.54 23,600 Large Shareholder 2,102,169 2016-09-16 Filing
ACRS $24.50 150,000 Large Shareholder 2,125,769 2016-09-16 Filing
ACRS $24.20 58,950 Large Shareholder 2,275,769 2016-09-15 Filing
ACRS $24.00 273,000 Large Shareholder 2,334,719 2016-09-15 Filing
ACRS $24.04 20,000 Large Shareholder 2,607,719 2016-09-15 Filing